ES2151646T3 - Procedimiento para la identificacion o dosificacion inmunologica de antigenos polipeptidicos. - Google Patents

Procedimiento para la identificacion o dosificacion inmunologica de antigenos polipeptidicos.

Info

Publication number
ES2151646T3
ES2151646T3 ES96430018T ES96430018T ES2151646T3 ES 2151646 T3 ES2151646 T3 ES 2151646T3 ES 96430018 T ES96430018 T ES 96430018T ES 96430018 T ES96430018 T ES 96430018T ES 2151646 T3 ES2151646 T3 ES 2151646T3
Authority
ES
Spain
Prior art keywords
specific
polypeptide antigen
sample
residue
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96430018T
Other languages
English (en)
Inventor
Frederic Jean
Gilles Kertesz
Beatrice Bourcier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IMMUNOTECH SA
Immunotech SAS
Original Assignee
IMMUNOTECH SA
Immunotech SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IMMUNOTECH SA, Immunotech SAS filed Critical IMMUNOTECH SA
Application granted granted Critical
Publication of ES2151646T3 publication Critical patent/ES2151646T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PROCEDIMIENTO DE IDENTIFICACION O DE DOSIFICACION DE UN ANTIGENO POLIPEPTIDICO X PARTICULAR EN EL QUE SE PROCEDE A UNA DETERMINACION INMUNOLOGICA DE LA PRESENCIA DE DICHO ANTIGENO POLIPEPTIDICO X EN UNA MUESTRA, CARACTERIZADO PORQUE SE TRATA IN VITRO LA MUESTRA MEDIANTE AL MENOS UN AGENTE REACTIVO, SOBRE UNA FUNCION EPSILON -NH{SUB,2} DE UN RESTO LISINA O SOBRE UNA FUNCION ALFA-NH{SUB,2} TERMINAL DE UN PEPTIDO, PARA EFECTUAR EL ACOPLAMIENTO DE UN RESTO DE DICHO AGENTE REACTIVO SOBRE DICHO ANTIGENO POLIPEPTIDICO X Y ASI OBTENER UN ANTIGENO POLIPEPTIDICO X MODIFICADO (ANTIGENO POLIPEPTIDICO XM), Y A CONTINUACION A LA DETERMINACION INMUNOLOGICA DE LA PRESENCIA DE DICHO ANTIGENO POLIPEPTIDICO X EN DICHA MUESTRA MEDIANTE AL MENOS UN ANTICUERPO PRODUCIDO POR INMUNIZACION CONTRA UN ANTIGENO POLIPEPTIDICO Y IDENTICO AL ANTIGENO POLIPEPTIDICO XM O A UN FRAGMENTO ANTIGENICO DE ESTE ANTIGENO XM.
ES96430018T 1996-01-18 1996-12-16 Procedimiento para la identificacion o dosificacion inmunologica de antigenos polipeptidicos. Expired - Lifetime ES2151646T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9600894A FR2743891B1 (fr) 1996-01-18 1996-01-18 Procede pour l'identification ou le dosage immunologique d'antigenes polypeptidiques

Publications (1)

Publication Number Publication Date
ES2151646T3 true ES2151646T3 (es) 2001-01-01

Family

ID=9488489

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96430018T Expired - Lifetime ES2151646T3 (es) 1996-01-18 1996-12-16 Procedimiento para la identificacion o dosificacion inmunologica de antigenos polipeptidicos.

Country Status (10)

Country Link
US (1) US5817468A (es)
EP (1) EP0785432B1 (es)
AT (1) ATE196362T1 (es)
AU (1) AU712896B2 (es)
CA (1) CA2193717A1 (es)
DE (1) DE69610283T2 (es)
DK (1) DK0785432T3 (es)
ES (1) ES2151646T3 (es)
FR (1) FR2743891B1 (es)
GR (1) GR3034962T3 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2931481B1 (fr) * 2008-05-23 2013-05-10 Covalab Anticorps specifique de la lysine propionylee/butyrylee, son procede d'obtention et ses applications
CA2940242C (en) 2014-02-20 2026-01-13 H. Lundbeck A/S Anti-acth antibodies and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE821053A (fr) * 1974-08-01 1975-04-14 Produit pour diagnostic par determination immunochimique
GB2090598B (en) * 1980-12-11 1984-03-21 Mini Agriculture & Fisheries Enzyme-immunoassay method
US4415546A (en) * 1981-05-12 1983-11-15 Janakiraman Ramachandran Biologically active analogs of ACTH and radioimmuno assay therefor
FR2605109B1 (fr) * 1986-10-13 1989-02-03 Ire Medgenix Sa Procede de dosage de la parathormone
DE3884235T2 (de) * 1987-02-27 1994-04-28 Eastman Kodak Co Agglutinationsreagens und Verfahren zu seiner Herstellung.
FR2658301A1 (fr) * 1990-02-14 1991-08-16 Caen Labo Biochimie Inst Rech Procede de mise en evidence et d'analyse de la degenerescence cellulaire.

Also Published As

Publication number Publication date
GR3034962T3 (en) 2001-02-28
EP0785432B1 (fr) 2000-09-13
DE69610283T2 (de) 2001-03-29
AU712896B2 (en) 1999-11-18
EP0785432A1 (fr) 1997-07-23
US5817468A (en) 1998-10-06
FR2743891A1 (fr) 1997-07-25
ATE196362T1 (de) 2000-09-15
DK0785432T3 (da) 2001-01-22
AU1221497A (en) 1997-07-31
CA2193717A1 (fr) 1997-07-19
DE69610283D1 (de) 2000-10-19
FR2743891B1 (fr) 1998-04-10

Similar Documents

Publication Publication Date Title
CU22615A1 (es) Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos
IL116617A0 (en) Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples
DE60034564D1 (de) Menschlicher cytokinrezeptor
GB2246780B (en) Immunodiagnostic assay for rheumatoid arthritis
AU635243B2 (en) Immunoassay of human osteocalcin, reagent and kit therefor, antihuman osteocalcin antibody, hybridoma producing said antibody, and method of producing said antibody
ES2151646T3 (es) Procedimiento para la identificacion o dosificacion inmunologica de antigenos polipeptidicos.
KR880014376A (ko) Hiv 특이 항원 영역의 모노클로날 항체 및 그 용법
EP0845540A4 (en) MONOCLONAL ANTIBODIES AND ANTIGENS RELATED TO HUMAN LUNG ADENOCARCINOMA AND IMMUNOASSAY METHOD USING THE SAME
IKURA et al. Thermally induced epitope regions of ovalbumin identified with monoclonal antibodies
CA2054689A1 (en) An immunoassay method for determining the specificity of binding of a monoclonal antibody to an antigen
ZA93123B (en) Peptides representing fragments of CMP, antibodies directed against the said peptides, and their uses
NO174005C (no) Monoklonalt antistoff, hybridom, og reagens for immunologisk analyse av x-hANP
Stähli et al. Monoclonal antibodies to thymosin α1
Kyurkchiev et al. Application of an immunological method to detect trace amounts of dried human semen
DE69012572D1 (de) Monoklonaler antikörper gegen acetylierte lysinabfälle in rekombinantem rindsomatotropin.
Würzner et al. Determination of the epitope specificities of monoclonal antibodies using unprocessed supernatants of hybridoma cultures
Poltoranina et al. Mixed precipitation in gel: A new method of identification and characterization of monoclonal antibodies
Vladyko et al. The isolation and characteristics of recombinant monoclonal antibodies to the Lassa virus
Kalashnikov et al. Evaluation of specificity of the test for β1-G-globulin in trophoblastic tumors by a quantitative immunoenzymic method
JPS6471480A (en) Cell line producing monoclonal antibody and monoclonal antibody produced therefrom
IT1268561B1 (it) Metodo per l'identificazione del virus a della vite (gva), anticorpi monoclonali (mab) contro gva e linea cellulare di ibridoma atta a
Drobyshevskaya et al. Monoclonal antibodies to streptococcal group A polysaccharide, cross-reactive with the mammalian connective tissue.
JPS6471481A (en) Cell line producing monoclonal antibody and monoclonal antibody produced therefrom

Legal Events

Date Code Title Description
FA2A Application withdrawn

Effective date: 19990212

FG2A Definitive protection

Ref document number: 785432

Country of ref document: ES